Phase I Trial of Docetaxel and Low-Dose Fractionated Radiation in the Treatment of Metastatic or Recurrent NSCLC
Status:
Terminated
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the maximum tolerated dose of low-dose radiation in
combination with Docetaxel in recurrent or metastatic non-small cell lung cancer for
second-line therapy.